Bladder microbiome study aims to unlock secrets of urinary diseases
NCT ID NCT07494864
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study from the University of Zurich is looking at how tiny organisms (microbes) and the immune system interact in the bladder. Researchers will collect samples from 800 adults with various urinary conditions, including infections, bladder pain, and overactive bladder, as well as healthy volunteers. The goal is to find patterns that could lead to better ways to diagnose or treat these common problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal new biomarkers or targets for better diagnosis and treatment of urinary tract diseases.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may take years to apply.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CATHETER-ASSOCIATED UTI (CAUTI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Balgrist University Hospital
RECRUITINGZurich, Canton of Zurich, 8008, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Could a simple blood or urine test spot bladder cancer earlier?
- Can heated chemotherapy beat bladder cancer without surgery?
- Can a Two-Drug bladder wash beat cancer recurrence?
- Bladder cancer surgery: what happens after the bladder is removed?
- Pelvic floor therapy put to the test against endometriosis pain